Serum levels of TGF-β were increased in lung cancer patients with lymph node metastasis compared with patients who were without lymph node metastasis, and the TGF-β levels were significantly higher in patients with stage III disease compared with patients who had stages I and II disease [112]. This evidence concerns the gene TGFB1 and metastatic malignant neoplasm in the lymph nodes.